This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Fibrinolytic system

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Fibrinolysis, the breakdown of fibrin polymer, occurs by at least two pathways resulting in the active agents protein C and plasmin. The latter is the better characterised and the term fibrinolysis is commonly taken to mean the plasmin pathway; protein C is discussed in the submenu.

Drugs which affect plasmin production are clinically important: accelerating agents include streptokinase; retarding agents include tranexamic acid.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.